Display options
Share it on

J Clin Diagn Res. 2016 Jun;10(6):BC04-8. doi: 10.7860/JCDR/2016/19775.8067. Epub 2016 Jun 01.

A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid Patients.

Journal of clinical and diagnostic research : JCDR

Sanjiv Kumar Bansal, Rakhee Yadav

Affiliations

  1. Associate Professor, Department of Biochemistry, SGT Medical College, Hospital and Research Institute , Budhera, Gurgaon, Haryana, India .
  2. Assistant Professor, Department of Biochemistry, SGT Medical College, Hospital and Research Institute , Budhera, Gurgaon, Haryana, India .

PMID: 27504276 PMCID: PMC4963636 DOI: 10.7860/JCDR/2016/19775.8067

Abstract

INTRODUCTION: Hypothyroidism is one of the most common metabolic disorders associated with dyslipidemia which poses a higher risk of Coronary Artery Disease (CAD) in such patients. Biochemical markers which can pick up the risk promptly are becoming imperative now-a-days and thus the assessment beyond the conventional lipid profile is the need of the hour.

AIMS: To assess the association of non-conventional lipid parameters like small dense Low Density Lipoprotein (sd LDL), oxidized Low Density Lipoprotein (ox LDL), Apolipoprotein A (Apo A1), Apolipoprotein B (Apo B) and Lipoprotein (a) {Lp(a)} in hypothyroid patients and compare their values with the conventional lipid parameters such as Total Cholesterol (TC), Triglyceride (TG), Low-Density Lipoprotein Cholesterol (LDL-C) and High-Density Lipoprotein Cholesterol (HDL-C).

MATERIALS AND METHODS: One hundred and thirty clinically proven patients of hypothyroidism aged 20-60 years and equal number of age and gender matched healthy individuals were included in this case control study. Serum sd LDL, ox LDL, Apo A1, Apo B, Lp (a), lipid profile, Thyroid Stimulating Hormone (TSH), Free Triiodothyronine (FT3) and Free Tetraiodothyronine (FT4) levels were measured in both the groups. The data was recorded and analysed on SPSS system. The results of cases and controls were compared by student t-test and one-way ANOVA. All the parameters were correlated with TSH by Pearson's correlation.

RESULTS: We found significantly high levels of sd LDL, ox LDL, Apo B, Lp (a), TC, TG, LDL-C in cases as compared to the controls. Ox LDL has shown maximum correlation with serum TSH (p<0.0001, r=0.801) followed by sd LDL (p<0.0001, r=0.792), Apo B (p<0.001, r=0.783) and LDL-C (p<0.001, r=0.741). Moreover, ox LDL and sd LDL were found to be increased in normolipidemic hypothyroid patients thereby giving a strong supportive evidence that estimation of these parameters can become fundamental in prompt identification of the high risk patients of CAD in hypothyroid population.

CONCLUSION: Non-conventional lipid parameters appear to be better markers for the assessment of cardiovascular risk in hypothyroidism and might help in the designing of the effective treatment protocols and areas of intervention by the clinicians as well as researchers.

Keywords: Apolipoprotein A; Apolipoprotein B; Coronary artery disease; Hypothyroidism; oxidized; small dense Low Density Lipoprotein

References

  1. Clin Endocrinol (Oxf). 2009 Jul;71(1):130-6 - PubMed
  2. Biochim Biophys Acta. 2007 Sep;1771(9):1216-25 - PubMed
  3. Mayo Clin Proc. 2013 Nov;88(11):1294-311 - PubMed
  4. Am J Med Sci. 2011 Aug;342(2):135-42 - PubMed
  5. Indian J Biochem Biophys. 2012 Apr;49(2):77-85 - PubMed
  6. Biochemistry. 2004 Feb 17;43(6):1626-32 - PubMed
  7. Crit Care. 2008;12(1):R1 - PubMed
  8. Cell. 2006 Jan 13;124(1):35-46 - PubMed
  9. J Am Coll Cardiol. 2008 Apr 15;51(15):1512-24 - PubMed
  10. Curr Opin Lipidol. 2006 Apr;17 (2):122-7 - PubMed
  11. Proc Soc Exp Biol Med. 2000 May;224(1):8-19 - PubMed
  12. Endocrinol Metab Clin North Am. 2007 Sep;36(3):595-615, v - PubMed
  13. J Clin Endocrinol Metab. 2008 Mar;93(3):888-94 - PubMed
  14. J Biol Chem. 2006 Jan 6;281(1):295-302 - PubMed
  15. Am Heart J. 2009 Jan;157(1):111-117.e2 - PubMed
  16. Diabetol Metab Syndr. 2010 Aug 18;2:55 - PubMed
  17. Crit Rev Clin Lab Sci. 2003 Feb;40(1):1-42 - PubMed
  18. Arch Intern Med. 2000 Jun 12;160(11):1573-5 - PubMed
  19. J Clin Endocrinol Metab. 2003 Jun;88(6):2438-44 - PubMed
  20. Eur Heart J. 2010 Dec;31(23):2844-53 - PubMed
  21. Gastroenterology. 2008 Apr;134(4):1127-36 - PubMed
  22. Lancet. 2003 Mar 1;361(9359):777-80 - PubMed
  23. Arterioscler Thromb Vasc Biol. 2005 Dec;25(12 ):2445-7 - PubMed
  24. Eur J Endocrinol. 2007 Feb;156(2):181-6 - PubMed
  25. Lancet. 2008 Jul 19;372(9634):224-33 - PubMed
  26. Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1750-4 - PubMed
  27. Atherosclerosis. 1998 Jun;138(2):289-99 - PubMed
  28. Thyroid. 2002 Apr;12(4):287-93 - PubMed
  29. J Biol Chem. 2003 Sep 5;278(36):34114-8 - PubMed
  30. Open Cardiovasc Med J. 2011;5:76-84 - PubMed
  31. Hormones (Athens). 2002 Oct-Dec;1(4):218-23 - PubMed
  32. Atherosclerosis. 2009 Mar;203(1):269-76 - PubMed
  33. Thyroid. 2011 Jan;21(1):5-11 - PubMed

Publication Types